Kassberg Thomas Richard
Passage Bio, Inc. · Director
Kassberg Thomas Richard is listed in filings as Director at Passage Bio, Inc.. This profile follows SEC Form 4 activity through May 21, 2026, including sale activity. Recent filings connect the profile to Passage Bio, Inc. (PASG) and Ultragenyx Pharmaceutical Inc (RARE). The current snapshot covers public activity from Oct 2, 2024 to May 21, 2026. Reported amounts are shown as $53.5K to $253.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
Latest Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $254k6k shares | SellMar 3, 2025 | $42.10 | $27.04 |